Skip to main content
Log in

Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget’s disease of bones: a pilot study

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

It has been shown that human calcitonin (hCT) is absorbed through the nasal mucosa when administered together with promoters like sodium glycocholate (SGC) or dihydrofusinate. The aim of this study was to compare the clinical and metabolic effects of intranasal (in) and intramuscular (im) hCT in patients with osteoporosis or with Paget’s disease of bones. Fifteen women with postmenopausal or with senile osteoporosis entered a randomized six months trial with in hCT (plus SGC) or with im hCT 100 U on alternate days. Six women in each group were treated for 2 months, and only four women in each group continued treatment for an additional 4 months period. In hCT, but not im hCT, reduced subjective pain, while urinary cAMP increased to a similar extent in the 2 groups. Other metabolic indexes and bone mineral content (BMC) were unchanged, no new fractures took place, and side effects were fewer with in than with im hCT. To confirm the analgesic effect of in hCT, twelve patients with Paget’s disease of bones were randomly treated for 20 days with in or im hCT 100 U/day: during the short period of treatment, pain was reduced by in, not by im hCT, and urinary cAMP excretion similarly increased in the two groups of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Buclin T., Randin J.P., Jacquet A.F., Azria M., Attinger M., Gomez F., Burckhardt P. The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcif. Tissue Int. 41: 252, 1987.

    Article  PubMed  CAS  Google Scholar 

  2. Reginster J.Y., Albert A., Lecart M.P., Lambelin P., Denis D., Deroisy R., Fontaine M.A., Franchimont P. One year controlled randomized trial of prevention of early post menopausal bone loss by intranasal calcitonin. Lancet 2: 1481, 1987.

    Article  PubMed  CAS  Google Scholar 

  3. Nagant de Deuxchaisnes C., Devogelaer J.P., Huaux J.P., Dufour J.P., Esselinckx W., Engelbeen J.P., Stasse P., Hermans P., De Buisseret J.P. New modes of administration of salmon calcitonin in Paget’s disease. Nasal spray and suppository. Clin. Orthop. 217: 56, 1987.

    PubMed  Google Scholar 

  4. Pontiroli A.E., Alberetto M., Pozza G. Intranasal calcitonin and plasma calcium concentration in normal subjects. Br. Med. J. 290: 1390, 1985.

    Article  CAS  Google Scholar 

  5. Pontiroli A.E., Alberetto M., Calderara A., Pajetta E., Pozza G. Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents. Eur. J. Clin. Pharmacol. 37: 427, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Wahner H.W., Riggs B.L., Beabout J.W. Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J. Nucl. Med. 18: 432, 1977.

    PubMed  CAS  Google Scholar 

  7. Pontiroli A.E., Alberetto M., Pajetta E., Calderara A., Pozza G., Manganelli V., Tessari L. Intranasal calcitonin and plasma calcium concentrations. Br. Med. J. 291: 54, 1985.

    Article  Google Scholar 

  8. Tamburini M., Selmi S., De Conno F., Ventafridda V. Semantic descriptors of pain. Pain 25: 187, 1987.

    Article  Google Scholar 

  9. Heath H., Sizemore G.W. Radioimmunoassay for calcitonin. Clin. Chem. 28: 1219, 1982.

    PubMed  CAS  Google Scholar 

  10. Goverde B.C., Veenkamp F.J.N. Routine assay of total urinary hydroxyproline based on resin catalysed hydrolysis. Clin. Chim. Acta 41: 29, 1972.

    Article  PubMed  CAS  Google Scholar 

  11. Azria M. The calcitonins. Physiology and pharmacology. Ed. Karger, Basel, 1989, p. 88.

    Google Scholar 

  12. Ardaillou R., Isaac R., Nivez M.P., Kuhn J.M., Cazor J.L., Fillastre J.P. Effect of salmon calcitonin on renal excretion of adenosine 3’, 5’ monophosphate in man. Horm. Metab. Res. 8: 136, 1976.

    Article  PubMed  CAS  Google Scholar 

  13. Caniggia A., Gennari C., Loré F., Nuti R., Galli M. Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3’, 5’- monophosphate in normal subjects and in pathological conditions. Eur. J. Clin. Invest. 10: 99, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Reginster J.Y., Franchimont P. Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin. Exp. Rheumatol. 3: 155, 1985.

    PubMed  CAS  Google Scholar 

  15. Gennari C., Francini G., Gonnelli S., Nami R., Dolore osseo, endorfine e calcitonine. In: Gennari C., Segre S. (Eds.), The effects of calcitonin in man. Masson, Paris, 1983, p. 213.

    Google Scholar 

  16. Duchateau G.S.M.J.E., Zuidema J., Merkus F.W.H.M. Bile salts and intranasal drug absorption. Int. J. Pharm. 31: 193, 1986.

    Article  CAS  Google Scholar 

  17. Hersey S.J., Jackson R.T. Effects of bile salts on nasal permeability in vitro. J. Pharm. Sci. 76: 876, 1987.

    Article  PubMed  CAS  Google Scholar 

  18. Moses A.C., Gordon G.S., Carey M.C., Flier J.S. Insulin administered intranasally as an insulin-bile salts aerosol. Effectiveness and reproducibility in normal and diabetic subjects. Diabetes 32: 1040, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Gordon G.S., Moses A.C., Silver R.D., Flier J.S., Carey M.C. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA 82: 7419, 1985.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Ikegami M., Agata Y., Elkady T., Hallman M., Berry D. Comparison of four surfactants: in vitro surface properties and response of preterm lambs to treatment at birth. Pediatrics 79: 38, 1987.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pontiroli, A.E., Pajetta, E., Calderara, A. et al. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget’s disease of bones: a pilot study. J Endocrinol Invest 14, 47–51 (1991). https://doi.org/10.1007/BF03350260

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350260

Keywords

Navigation